Congenital Heart

This Congenital Heart Disease channel includes news and new technology to diagnose, treat and manage congenital heart disease. This includes transposed vessels, tetralogy of Fallot, pediatric cardiomyopathy, pulmonary heart valves, pulmonary atresia, patent foramen ovale (PFO),  atrial septal defect (ASD) and ventricular septal defect (VSD). 

University of Arizona Leads Statewide Study of Congenital Heart Defects
News | Congenital Heart | October 24, 2019

October 24, 2019 — Investigators at the University of Arizona Steele Children's Research Center are leading a...

Abbott Receives European CE Mark for Two Pediatric Heart Devices
News | Congenital Heart | September 20, 2019

September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm...

Max and Debra Ernst Heart Center Opening at Beaumont Hospital, Royal Oak
News | Heart Failure | September 20, 2019

September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept...

Pediatricians Assess How to Personalize Hypertension Treatment in Children
News | Hypertension | July 29, 2019

July 29, 2019  — High blood pressure among...

Researchers File Patent for Tiny Blood Flow Sensor

Image courtesy of Flinders University

News | Implantable Cardiac Monitor (ICM) | July 09, 2019

July 9, 2019 — South Australian researchers are developing a tiny fiber-optic sensor, which has the potential to...

Gore Cardioform ASD Occluder Receives FDA Approval
Technology | Structural Heart Occluders | June 10, 2019

June 10, 2019 – W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s)...

Hypertension Found in Children Exposed to Flower Pesticides
News | Congenital Heart | June 03, 2019

June 3, 2019 — Researchers at University of California San Diego School of Medicine found...

Fragmin (dalteparin sodium) injection was cleared by the FDA for use in pediatric patients. It was initially approved by the FDA in 1994 for adults and is a type of heparin.

Fragmin (dalteparin sodium) injection is now cleared by the FDA for use in pediatric patients. It was initially approved by the FDA in 1994 for adults and is a type of heparin.

Technology | Antiplatelet and Anticoagulation Therapies | May 17, 2019

May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection...

Edwards Recalls Miller and Fogarty Balloon Dilation Atrioseptostomy Catheters
News | Congenital Heart | April 29, 2019

April 29, 2019 — Edwards Lifesciences is recalling the Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation...

New Pediatric Blood Pressure Guidelines Improve Premature Heart Disease Identification
News | Congenital Heart | April 22, 2019

April 22, 2019 — New guidelines that classified more...

SCAI Offers Recommendations for Safe Use of PFO Closure Technologies. SCAI said completion of the randomized trials demonstrating the superiority of PFO closure and medical therapy over medical therapy alone
News | Structural Heart Occluders | March 27, 2019

March 27. 2019 — A newly released expert consensus statement provides recommendations for the safe and effective...

Overlay Init